Home > Insider Trading > Filing (0001415889-23-013038)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1730430	Kiniksa Pharmaceuticals Ltd.	KNSA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1741533	F. John Paolini	C/O Kiniksa Pharmaceuticals, Ltd. Clarendon House 2 Church Street Hamilton D0 HM 11	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Share	Acquisiton	2023-09-01	2,498	$0.00	44,408	No	4	M	Direct
Class A Common Share	Disposition	2023-09-01	734	$17.76	43,674	No	4	F	Direct
Class A Common Share	Acquisiton	2023-09-02	1,725	$0.00	45,399	No	4	M	Direct
Class A Common Share	Disposition	2023-09-02	507	$17.76	44,892	No	4	F	Direct
Class A Common Share	Acquisiton	2023-09-05	400	$1.86	45,292	No	4	M	Direct
Class A Common Share	Disposition	2023-09-05	400	$17.53	44,892	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Share	Restricted Share Unit	Disposition	2023-09-01	2,498	$0.00	2,498	$0.00
Class A Common Share	Restricted Share Unit	Acquisiton	2023-09-01	6,496	$0.00	6,496	$0.00
Class A Common Share	Share Option	Acquisiton	2023-09-01	38,974	$0.00	38,974	$17.76
Class A Common Share	Restricted Share Unit	Disposition	2023-09-02	1,725	$0.00	1,725	$0.00
Class A Common Share	Share Option	Disposition	2023-09-05	400	$0.00	400	$1.86

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,492		No	4	M	Direct
6,496		No	4	A	Direct
38,974	2033-08-31	No	4	A	Direct
3,450		No	4	M	Direct
139,817	2026-09-13	No	4	M	Direct

Footnotes

Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.50 to $17.56. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2022.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2023.
The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 2, 2021.
The option is fully vested and exercisable.